دورية أكاديمية
Correlation between Physician-Administered International Prostate Symptoms Score and Peak Urine Flow Rate in Assessment of Benign Prostatic Enlargement Patients.
| العنوان: | Correlation between Physician-Administered International Prostate Symptoms Score and Peak Urine Flow Rate in Assessment of Benign Prostatic Enlargement Patients. |
|---|---|
| المؤلفون: | Affusim EA; Department of Surgery, College of Medicine, Odumegwu Ojukwu University, Awka, Anambra State, Nigeria., Amu OC; Department of Surgery, College of Medicine, University of Nigeria- Enugu Campus, Nigeria., Eneje CL; Department of Surgery, Enugu State University Teaching Hospital, Parklane, Enugu, Nigeria., Iwenofu C; Department of Surgery, University of Nigeria Teaching Hospital, Enugu, Nigeria., Ugwumba F; Department of Surgery, College of Medicine, University of Nigeria- Enugu Campus, Nigeria. |
| المصدر: | Nigerian journal of clinical practice [Niger J Clin Pract] 2023 Nov 01; Vol. 26 (11), pp. 1642-1646. Date of Electronic Publication: 2023 Dec 04. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Publications Country of Publication: India NLM ID: 101150032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1119-3077 (Print) NLM ISO Abbreviation: Niger J Clin Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Mumbai : Medknow Publications Original Publication: [Lagos?] : Medical and Dental Consultants' Association of Nigeria |
| مواضيع طبية MeSH: | Prostate* , Prostatic Hyperplasia*/diagnosis, Male ; Humans ; Prospective Studies ; Quality of Life ; Urination |
| مستخلص: | Background: To determine the correlation between international prostate symptom score (IPSS) questionnaire, completed by benign prostatic enlargement patients with the aid of their physicians and the peak urine flow rate from uroflowmetry. Materials and Methods: This was a prospective study carried out over a period of one year (which year and which period). IPSS questionnaire was administered, and uroflowmetry done for 76 consecutive patients from urology clinic of University of Nigeria Teaching Hospital (UNTH) who consented to the study. Results: Seventy-six patients were recruited for the study. The mean age of the patients was 63.53 ± 9.84. Using the international prostate symptom score to assess symptoms severity, 16 patients had mild symptoms, 36 patients had moderate symptoms, while 24 patients had severe symptoms. The means quality-of-life score was 4.42 ± 1.83. Fifty-eight patients had obstructed peak flow rate (Qmax) on uroflowmetry, 14 patients had equivocal Qmax, while 4 patients had normal Qmax. Statistically significant, negative medium correlations were observed between Qmax and total IPSS, Qmax and the IPSS voiding and storage subscores, as well as Qmax and disease specific quality-of-life score (QoL). Conclusion: There is a statistically significant medium negative correlation between total IPSS and Qmax. This negative medium correlation was also observed between Qmax and IPSS subscores and between Qmax and QoL. (Copyright © 2023 Copyright: © 2023 Nigerian Journal of Clinical Practice.) |
| References: | Cruz F, Desgrandchamps F. New concept and pathophysiology of lower urinary tract symptoms in men. Eur Urol Suppl 2010;9:472–6. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988;12:619–33. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474–9. Ezeanyika L, Ejike C, Obidoa O, Elom S. Prostate disorders in an apparently normal Nigerian population 1:Prevalence. Biokemistri 2006;18:127–32. Dmochowski RR. Bladder outlet obstruction:Etiology and evaluation. Rev Urol 2005;7 (Suppl 6):S3–13. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64:118–40. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549–64. Jindal T, Sinha RK, Mukherjee S, Mandal SN, Karmakar D. Misinterpretation of the international prostate symptom score questionnaire by Indian patients. Indian J Urol 2014;30:252–5. Oztürk MI, Koca O, Keleş MO, Güneş M, Kaya C, Karaman MI. International prostate symptom score:Really Appreciated by all patients or not?. Urol J 2011;8:227–30. Ogwuche EI, Dakum NK, Amu CO, Dung ED, Udeh E, Ramyil VM, et al. Problems of administration of the international prostate symptom score in a developing economy. Ann Afr Med 2013;3:171–3. Schfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices:Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261–74. Garg R, Singla S, Garg R, Singla A, Sharma S, Singh J, et al. Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Clin Diagnostic Res 2014;8:1–3. Haylen BT, Ashby D, Sutherst JR, Frazer MI, West CR. Maximum and average urine flow rates in normal male and female populations-The Liverposl Nomograms. British journal of urology 1989;64:30–38. Reynard JM, Yang Q, Donovan JL, Peters TJ, Schafer W, De La Rosette JJMCH, et al. The ICS-'BPH'Study:Uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 1998;82:619–23. National bureau of statistics. The National Literacy survey June 2010; media and marketing communications company group National commission for mass literacy, adult and non-formal education. Bock-Oruma AAA, Dienye POP, Oghu ISI. Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria. South African Fam Pract 2013;55:467–72. Amu OC, Udeh EI, Ugochukwu AI, Dakum NK, Ramyil VM. The value of international prostate symptom scoring system in the management of bph in jos, Nigeria. Niger J Clin Pract 2013;16:273–8. Oranusi CK, Nwofor AE, Mbonu O. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia. Niger J Clin Pract 2017;20:454–8. Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age:Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995;75:622–30. Ojewola RW, Oridota ES, Balogun OS, Alabi TO, Ajayi AI, Olajide TA, et al. Prevalence of clinical benign prostatic hyperplasia amongst community-dwelling men in a South-Western Nigerian rural setting:A cross-sectional study. Afr J Urol 2017;23:109–15. Sountoulides P, van Dijk MM, Wijkstra H, de la Rosette JJMCH, Michel MC. Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. World J Urol 2010;28:3–8. |
| تواريخ الأحداث: | Date Created: 20231204 Date Completed: 20231205 Latest Revision: 20231205 |
| رمز التحديث: | 20240628 |
| DOI: | 10.4103/njcp.njcp_279_23 |
| PMID: | 38044768 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1119-3077 |
|---|---|
| DOI: | 10.4103/njcp.njcp_279_23 |